BR9913183A - Composto, uso do mesmo, processo para prepará-lo, processo para tratar um indivìduo humano ou animal, e, composição farmacêutica - Google Patents
Composto, uso do mesmo, processo para prepará-lo, processo para tratar um indivìduo humano ou animal, e, composição farmacêuticaInfo
- Publication number
- BR9913183A BR9913183A BR9913183-8A BR9913183A BR9913183A BR 9913183 A BR9913183 A BR 9913183A BR 9913183 A BR9913183 A BR 9913183A BR 9913183 A BR9913183 A BR 9913183A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- treat
- prepare
- human
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSTO, USO DO MESMO, PROCESSO PARA PREPARá-LO, PROCESSO PARA TRATAR UM INDIVìDUO HUMANO OU ANIMAL, E, COMPOSIçãO FARMACêUTICA". Um composto de fórmula (I) em que R¹ é fenila substituída por um ou mais átomos de halogênio; R² é -NH~ 2~; R³ é -NH~ 2~ ou hidrogênio; R^ 4^ é -CXNR^ a^R^ b^, -CXNH-(CH~ 2~)~ y~-NR^ a^R^ b^; em que X é = O ou = S; y é um zero inteiro zero, 1 ou 2; R^ a^ e R^ b^, que podem ser iguais ou diferentes, são selecionados de hidrogênio e C1-C4-alquila ou juntos com o átomo de nitrogênio a que eles são ligados formam um heterociclo de 5- ou 6 membros, contendo um ou dois heteroátomos, heterociclo este podendo ser mais substituído com um ou mais grupos C1-C4-alquila; e seus derivados farmaceuticamente aceitáveis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9818881.6A GB9818881D0 (en) | 1998-08-28 | 1998-08-28 | Compounds |
PCT/EP1999/006248 WO2000012488A1 (en) | 1998-08-28 | 1999-08-26 | Pyrazine compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9913183A true BR9913183A (pt) | 2001-05-15 |
Family
ID=10838055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9913183-8A BR9913183A (pt) | 1998-08-28 | 1999-08-26 | Composto, uso do mesmo, processo para prepará-lo, processo para tratar um indivìduo humano ou animal, e, composição farmacêutica |
Country Status (15)
Country | Link |
---|---|
US (2) | US6503909B1 (pt) |
EP (1) | EP1107960A1 (pt) |
JP (1) | JP2002523499A (pt) |
KR (1) | KR20010079696A (pt) |
CN (1) | CN1324349A (pt) |
AU (1) | AU5624999A (pt) |
BR (1) | BR9913183A (pt) |
CA (1) | CA2341543A1 (pt) |
CO (1) | CO5130006A1 (pt) |
GB (1) | GB9818881D0 (pt) |
MA (1) | MA26681A1 (pt) |
PE (1) | PE20001022A1 (pt) |
TR (1) | TR200100603T2 (pt) |
TW (1) | TW429255B (pt) |
WO (1) | WO2000012488A1 (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1500653A1 (en) * | 2000-02-16 | 2005-01-26 | Neurogen Corporation | Substituted arylpyrazines |
MXPA02007868A (es) | 2000-02-16 | 2003-02-10 | Neurogen Corp | Arilpirazinas sustituidas. |
GB0010971D0 (en) * | 2000-05-05 | 2000-06-28 | Glaxo Group Ltd | Process |
JP4901102B2 (ja) * | 2002-05-03 | 2012-03-21 | エクセリクシス, インク. | プロテインキナーゼモジュレーターおよびその使用方法 |
US7704995B2 (en) | 2002-05-03 | 2010-04-27 | Exelixis, Inc. | Protein kinase modulators and methods of use |
CA2496197A1 (en) | 2002-08-20 | 2004-03-04 | Neurogen Corporation | 5-substituted-2-arylpyrazines as modulators of crf receptors |
EA015166B1 (ru) * | 2003-06-16 | 2011-06-30 | Ю-Си-Би Мэньюфэкчуринг, Инк. | Иммуногенные пептиды склеростина (sost), индуцирующие образование специфических антител |
JPWO2005095613A1 (ja) * | 2004-03-30 | 2008-02-21 | ジェノミディア株式会社 | Rad51の発現抑制剤、該発現抑制剤を有効成分として含む医薬、及びその使用 |
US7592429B2 (en) | 2005-05-03 | 2009-09-22 | Ucb Sa | Sclerostin-binding antibody |
US20100015665A1 (en) * | 2006-11-10 | 2010-01-21 | Ucb Pharma S.A. | Antibodies and diagnostics |
US20100036091A1 (en) * | 2006-11-10 | 2010-02-11 | Amgen Inc. | Antibody-based diagnostics and therapeutics |
CL2008002775A1 (es) * | 2007-09-17 | 2008-11-07 | Amgen Inc | Uso de un agente de unión a esclerostina para inhibir la resorción ósea. |
US20110044978A1 (en) * | 2007-12-14 | 2011-02-24 | Amgen Inc. | Method for treating bone fracture |
KR20230135541A (ko) * | 2022-03-16 | 2023-09-25 | (주)아름테라퓨틱스 | 신규한 화합물 및 이의 체크포인트 키나제 2 저해 용도 |
CN115611700B (zh) * | 2022-10-11 | 2024-06-14 | 辽宁东大光明化工科技有限责任公司 | 一种1-溴-2,5-二氯-3-氟苯的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3575975A (en) | 1968-07-25 | 1971-04-20 | Merck & Co Inc | Process for the preparation of 3-aminopyrazinoylureas |
US3544568A (en) * | 1969-03-18 | 1970-12-01 | Merck & Co Inc | 3-amino-5,6-substituted pyrazinamides |
US4402958A (en) | 1981-11-19 | 1983-09-06 | American Cyanamid Company | Novel (substituted phenyl)-1,2,4-triazolo (4,3-A)pyrazines and novel 2-hydrazino-(substituted phenyl)pyrazine intermediates |
MA26473A1 (fr) | 1997-03-01 | 2004-12-20 | Glaxo Group Ltd | Composes pharmacologiquement actifs. |
-
1998
- 1998-08-28 GB GBGB9818881.6A patent/GB9818881D0/en not_active Ceased
-
1999
- 1999-08-26 US US09/762,295 patent/US6503909B1/en not_active Expired - Fee Related
- 1999-08-26 KR KR1020017002509A patent/KR20010079696A/ko not_active Application Discontinuation
- 1999-08-26 BR BR9913183-8A patent/BR9913183A/pt not_active Application Discontinuation
- 1999-08-26 TR TR2001/00603T patent/TR200100603T2/xx unknown
- 1999-08-26 CA CA002341543A patent/CA2341543A1/en not_active Abandoned
- 1999-08-26 EP EP99942919A patent/EP1107960A1/en not_active Withdrawn
- 1999-08-26 JP JP2000567518A patent/JP2002523499A/ja active Pending
- 1999-08-26 CN CN99812550A patent/CN1324349A/zh active Pending
- 1999-08-26 PE PE1999000868A patent/PE20001022A1/es not_active Application Discontinuation
- 1999-08-26 WO PCT/EP1999/006248 patent/WO2000012488A1/en not_active Application Discontinuation
- 1999-08-26 AU AU56249/99A patent/AU5624999A/en not_active Abandoned
- 1999-08-27 MA MA25746A patent/MA26681A1/fr unknown
- 1999-08-27 CO CO99054338A patent/CO5130006A1/es unknown
- 1999-08-27 TW TW088114723A patent/TW429255B/zh not_active IP Right Cessation
-
2002
- 2002-08-12 US US10/216,399 patent/US20030022904A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TR200100603T2 (tr) | 2001-07-23 |
GB9818881D0 (en) | 1998-10-21 |
WO2000012488A1 (en) | 2000-03-09 |
US20030022904A1 (en) | 2003-01-30 |
JP2002523499A (ja) | 2002-07-30 |
CO5130006A1 (es) | 2002-02-27 |
MA26681A1 (fr) | 2004-12-20 |
PE20001022A1 (es) | 2000-10-16 |
AU5624999A (en) | 2000-03-21 |
CA2341543A1 (en) | 2000-03-09 |
US6503909B1 (en) | 2003-01-07 |
EP1107960A1 (en) | 2001-06-20 |
CN1324349A (zh) | 2001-11-28 |
TW429255B (en) | 2001-04-11 |
KR20010079696A (ko) | 2001-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9913183A (pt) | Composto, uso do mesmo, processo para prepará-lo, processo para tratar um indivìduo humano ou animal, e, composição farmacêutica | |
HUP0105414A2 (hu) | Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
BR9916282A (pt) | Composto, uso de um um composto e método de tratamento | |
BR0014133A (pt) | Uso de um composto, composto, métodos de preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica | |
PT1263725E (pt) | Novos compostos | |
BR0016420A (pt) | Aminotiazóis inibidores de cinases dependentes de ciclinas | |
IT1311923B1 (it) | Composti farmaceutici. | |
FI934274A0 (fi) | N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner | |
SE9604786D0 (sv) | New compounds | |
ES2103479T3 (es) | Derivados de anilida. | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
GEP20032913B (en) | Thienylazolylalcoxyethanamines, Their Preparation and Their Application as Medicaments | |
NO974695D0 (no) | Farmasöytisk preparat inneholdende benzimidazol for inhibering av vekst av cancer | |
YU47116B (sh) | Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata | |
HUP0103203A2 (hu) | Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
PT992509E (pt) | Novos derivados macrolidos | |
BR9814376A (pt) | Composto ou um pró-medicamento correspondente, ou um sal farmaceuticamente aceitável ou solvato de um tal composto ou um pró-medicamento deste, uso destes, composição farmacêutica, processo para o tratamento de um paciente humano ou animal não humano sofrendo de, ou sujeito a, condições que podem ser melhoradas pela admnistração de um inibidor da adesão celular mediada por &4ß1, e, resina | |
BR9910448A (pt) | Azóis solúveis em água como antifúngicos de amplo aspectro | |
NO942301L (no) | Imidazokinazolinforbindelser og deres fremstilling og anvendelse | |
DK624989D0 (da) | Hidtil ukendte forbindelser | |
NO991581L (no) | N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
ES2099180T3 (es) | Derivados del benzopirano y procedimientos para su preparacion. | |
ES528461A0 (es) | Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles | |
BR0008130A (pt) | Composto, composição farmacêutica, e, uso do composto ou de seu sal farmaceuticamente aceitável |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |